New Jersey

New Jersey Law360 provides breaking news and analysis on legal and regulatory issues in New Jersey. Coverage includes high-stakes litigation, policy developments, and corporate deals affecting the state.



Sign up for a 7-day FREE trial today!



Latest News in New Jersey

  • September 09, 2026

    21 States Want Changes To Endangered Species Act Blocked

    California, Massachusetts, Washington and 18 other states on Wednesday filed a pair of suits challenging the Trump administration's recent changes to how the Endangered Species Act is implemented, claiming that the rules drastically weaken safeguards for the most vulnerable species and were rolled out unlawfully.

  • September 09, 2026

    Pa. Ch. 7 Judge Pans NJ AG In Remanding 'Ghost Gun' Suit

    A Pennsylvania federal bankruptcy judge says an alleged seller of "ghost gun" kits improperly tried to remove a civil suit filed by the New Jersey Attorney General's office to his court, but chided the AG for assuming that her lawsuit was immune from the automatic bankruptcy stay.

  • September 09, 2026

    States Say DOT's Driver Data Demand Is Immigration Pretext

    The Democratic-led states asking a Virginia federal judge to stop the Trump administration from accessing the Social Security numbers of commercial drivers nationwide for immigration enforcement backed up their request for an injunction Wednesday, saying the federal government is using post hoc rationalizations to defend its data demands.

  • September 09, 2026

    States, Amici Ask Justices To Keep Mail Ballot Rules On Ice

    Nearly half of the states and the District of Columbia urged the U.S. Supreme Court on Wednesday to leave in place a federal judge's order blocking the U.S. Postal Service from enforcing new mail-in ballot regulations in this year's midterms, arguing the changes are a major political decision USPS had no authority to make. 

  • September 09, 2026

    3rd Circ. Stands By Upholding Lipitor Pay-For-Delay Suit Toss

    The Third Circuit has refused to rethink its decision backing a New Jersey district court's dismissal of an antitrust suit alleging Ranbaxy Laboratories Ltd. conspired to delay a generic version of the cholesterol drug Lipitor.

See more New Jersey news

New Jersey

Areas of Coverage

  • AGENCIES
  • New Jersey Attorney General’s Office
  • Casino Control Commission
  • New Jersey State Commission of Investigation
  • New Jersey Transit
  • Motor Vehicle Commission
  • State of New Jersey Board of Public Utilities
  • ENFORCEMENT
  • Investigations and enforcement actions by state and federal prosecutors
  • LITIGATION
  • Antitrust litigation
  • Class actions
  • Environmental suits
  • Labor and employment issues
  • Intellectual property cases
  • Product liability and consumer protection disputes
  • Securities disputes
  • Bankruptcy proceedings
  • TRANSACTIONS
  • Mergers, acquisitions, and joint ventures involving New Jersey companies
  • Real estate deals
  • PROFILES
  • Nominations, appointments, and elections of judges and agency officials in New Jersey
  • Personnel moves
  • Profiles of New Jersey judges, litigators, and firms

Readership

  • Lawyers at top law firms practicing in New Jersey
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys working with New Jersey-based companies
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals